Abstract
Depression is a highly debilitating and life-threatening psychiatric disorder. The classical antidepressants are still not adequate due to undesirable side effects. Therefore, the development of new drugs for depression treatment is an urgent strategic to achieving clinical needs. Licorisoflavan A is a bioactive ingredient isolated from Glycyrrhizae Radix and has been recently reported for neuroprotective effects. In this study, the antidepressant-like effect and neural mechanism of licorisoflavan A were explored. In the mice behavioral despair test, we observed that licorisoflavan A exhibited powerful antidepressant-like effect in forced swimming test (FST), tail suspension test (TST), without affecting locomotor activity in open field test (OFT). Additionally, licorisoflavan A administration significantly restored Chronic mild stress (CMS)-induced changes in sucrose preference test (SPT), FST, and TST, without altering the locomotion in OFT. In chronical-stimulated mice, the licorisoflavan A treatment effectively attenuated the expressions of Brain-derived neurotrophic factor (BDNF), tyrosine kinase B (TrkB), the phosphorylations of cAMP response element binding protein (CREB), extracellular signal-regulated kinase (ERK)-1/2, eukaryotic elongation factor 2 (eEF2), mammalian target of rapamycin (mTOR), initiation factor 4E-binding protein 1 (4E-BP-1), and p70 ribosomal protein S6 kinase (p70S6K) in hippocampus of CMS-induced mice. Additionally, licorisoflavan A could reverse the decreases in synaptic proteins post-synaptic density protein 95 (PSD-95) and α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor subunit glutamate receptor 1 (GluR1) caused by CMS, and its antidepressant-like effect was blocked by the AMPA receptor antagonist NBQX. These findings served as preclinical evidence that licorisoflavan A exerted potent antidepressant-like effects involving BDNF-TrkB pathway and AMPA receptors. Licorisoflavan A might be used as a potential medicine against depression-like disorder.
Similar content being viewed by others
Abbreviations
- FST:
-
Forced swimming test
- TST:
-
Tail suspension test
- SPT:
-
Sucrose preference test
- OFT:
-
Open field test
- CMS:
-
Chronic mild stress
- BDNF:
-
Brain-derived neurotrophic factor
- TrkB:
-
Tyrosine kinase B
- CREB:
-
cAMP response element binding protein
- ERK:
-
Extracellular signal-regulated kinase
- eEF2:
-
Eukaryotic elongation factor 2
- mTOR:
-
Mammalian target of rapamycin
- 4E-BP-1:
-
4E-binding protein 1
- p70S6K:
-
p70 ribosomal protein S6 kinase
- PSD-95:
-
Post-synaptic density protein 95
- AMPA:
-
α-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid
- GluR1:
-
Glutamate receptor 1
- NBQX:
-
2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline
References
Lai JS, Hiles S, Bisquera A, Hure AJ, McEvoy M, Attia J (2014) A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr 99(1):181–197. https://doi.org/10.3945/ajcn.113.069880
Jernigan CS, Goswami DB, Austin MC, Iyo AH, Chandran A, Stockmeier CA, Karolewicz B (2011) The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatr 35(7):1774–1779
World Health Organization (2001) The World Health Report 2001: Mental health: new understanding, new hope. World Health Organization, Geneva
Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, Oneil A, Hayley AC, Pasco JA, Anderson G, Jacka FN (2014) Oxidative and nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45:46–62
Bjorkholm C, Monteggia LM (2016) BDNF—a key transducer of antidepressant effects. Neuropharmacology 102:72–79
Chen B, Dowlatshahi D, Macqueen GM, Wang J, Young LT (2001) Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatr 50(4):260–265
Leary OFO, Wu X, Castren E (2009) Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling. Psychoneuroendocrinology 34(3):367–381
Neis VB, Moretti M, Bettio LEB, Ribeiro CM, Rosa PB, Goncalves FM, Lopes MW, Leal RB, Rodrigues ALS (2016) Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling. Eur Neuropsychopharmacol 26(6):959–971
Zhang K, Xu T, Yuan Z, Wei Z, Yamaki VN, Huang M, Huganir RL, Cai X (2016) Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine. Sci Signaling 9(458):123
Duman RS (2014) Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci 16(1):11–27
Immadisetty K, Geffert LM, Surratt CK, Madura JD (2013) New design strategies for antidepressant drugs. Expert Opin Drug Discov 8(11):1399–1414
Nakajima S, Suzuki T, Watanabe K, Kashima H, Uchida H (2010) Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Prog Neuropsychopharmacol Biol Psychiatr 34(2):259–264
Lee JR, Park SJ, Lee H, Jee SY, Seo J, Kwon YK, Kwon TK, Kim SC (2009) Hepatoprotective activity of licorice water extract against cadmium-induced toxicity in rats. Evid-Based Complement Altern Med 6(2):195–201
Zhao Z, Wang W, Guo H, Zhou D (2008) Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats. Behav Brain Res 194(1):108–113
Park H, Shim HS, Kim H, Kim KS, Lee H, Hahm D, Shim I (2010) Effects of glycyrrhizae radix on repeated restraint stress-induced neurochemical and behavioral responses. Korean J Physiol Pharmacol 14(6):371–376
Zhu Z, Tao W, Li J, Guo S, Qian D, Shang E, Su S, Ja Duan (2016) Rapid determination of flavonoids in licorice and comparison of three licorice species. J Sep Sci 39(3):473–482
Su Q, Tao W, Huang H, Du Y, Chu X, Chen G (2016) Protective effect of liquiritigenin on depressive-like behavior in mice after lipopolysaccharide administration. Psychiatr Res 240:131–136
Zhou Y-z, Li X, Gong W-x, Tian J-s, Gao X-x, Gao L, Zhang X, Du G-h, Qin X-m (2017) Protective effect of isoliquiritin against corticosterone-induced neurotoxicity in PC12 cells. Food Funct 8(3):1235–1244
Su GY, Yang JY, Wang F, Ma J, Zhang K, Dong YX, Song SJ, Lu XM, Wu CF (2014) Antidepressant-like effects of Xiaochaihutang in a rat model of chronic unpredictable mild stress. J Ethnopharmacol 152(1):217–226
Fan ZZ, Zhao WH, Guo J, Cheng RF, Zhao JY, Yang WD, Wang YH, Li W, Peng XD (2012) Antidepressant activities of flavonoids from Glycyrrhiza uralensis and its neurogenesis protective effect in rats. Acta Pharmaceutica Sinica 47(12):1612–1617
Tao W, Duan J, Yang N, Tang Y, Liu M, Qian Y (2012) Antithrombotic phenolic compounds from Glycyrrhiza uralensis. Fitoterapia 83(2):422–425
Tang J, Xue W, Xia B, Ren L, Tao W, Chen C, Zhang H, Wu R, Wang Q, Wu H (2015) Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice. Sci Rep 5(1):13573–13573
Adachi M, Barrot M, Autry AE, Theobald DEH, Monteggia LM (2008) Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiat 63(7):642–649
Opal Klenotich SC, Morais M, Bessa J, Winkle J, Doukas D, Kay LJ, Sousa N, Dulawa SM (2014) Serotonin 2C receptor antagonists induce fast-onset antidepressant effects. Mol Psychiatr 19(10):1106–1114
Hodes GE, Kana V, Menard C, Merad M, Russo SJ (2015) Neuroimmune mechanisms of depression. Nat Neurosci 18(10):1386–1393
Shi H, Zhu W, Liu J, Luo Y, Si J, Wang S, Xue Y, Ding Z, Shi J, Lu L (2012) PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3. Neuropsychopharmacology 37(12):2671–2683
Renard CE, Dailly E, David DJ, Hascoet M, Bourin M (2003) Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 17(4):449–455
Carr GV, Lucki I (2011) The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology 213:265–287
Racagni G, Popoli M (2008) Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci 10(4):385–400
Yuluğ B, Ozan E, Gönül AS, Kilic E (2009) Brain-derived neurotrophic factor, stress and depression: a minireview. Brain Res Bull 78(6):267–269
Mao Q, Xian Y, Ip S, Tsai S, Che C (2010) Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behav Brain Res 210(2):171–177
Xue W, Zhou X, Yi N, Jiang L, Tao W, Wu R, Wang D, Jiang J, Ge X, Wang Y (2013) Yueju pill rapidly induces antidepressant-like effects and acutely enhances BDNF expression in mouse brain. Evidence-Based Complem Altern Med 2013:184367–184367
Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9(4):519–525
Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33(1):88–109
Lepack AE, Bang E, Lee B, Dwyer JM, Duman RS (2016) Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures. Neuropharmacology 111:242–252
Liu R-J, Lee FS, Li X-Y, Bambico F, Duman RS, Aghajanian GK (2012) Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatr 71(11):996–1005
Trang T, Beggs S, Salter MW (2011) Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol 7(1):99–108
Costa MS, Botton PH, Mioranzza S, Ardais AP, Moreira JD, Souza DO, Porciúncula LO (2008) Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus. Neurochem Int 53(3–4):89–94
Tian F, Hu XZ, Wu X, Jiang H, Pan H, Marini AM, Lipsky RH (2009) Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter 1. J Neurochem 109(5):1375–1388
Ko Y-H, Kwon S-H, Lee S-Y, Jang C-G (2017) Liquiritigenin ameliorates memory and cognitive impairment through cholinergic and BDNF pathways in the mouse hippocampus. Arch Pharmacal Res 40(10):1209–1217
Choi JE, Park D-M, Chun E, Choi JJ, Seo JH, Kim S, Son J, Do M, Kim SY, Park Y-C (2017) Control of stress-induced depressive disorders by So-ochim-tang-gamibang, a Korean herbal medicine. J Ethnopharmacol 196:141–150
Tao W, Dong Y, Su Q, Wang H, Chen Y, Xue W, Chen C, Xia B, Duan J, Chen G (2016) Liquiritigenin reverses depression-like behavior in unpredictable chronic mild stress-induced mice by regulating PI3K/Akt/mTOR mediated BDNF/TrkB pathway. Behav Brain Res 308:177–186
Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475(7354):91–95
Rodgers EE, Theibert AB (2002) Functions of PI 3-kinase in development of the nervous system. Int J Dev Neurosci 20(3):187–197
Ota KT, Liu R, Voleti B, Maldonadoaviles JG, Duric V, Iwata M, Dutheil S, Duman CH, Boikess S, Lewis DA (2014) REDD1 is essential for stress-induced synaptic loss and depressive behavior. Nat Med 20(5):531–535
Hashimoto K (2011) Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine. Expert Rev Neurother 11(1):33–36
Kim K, Yang J, Zhong X, Kim M, Kim YS, Lee HW, Han S, Choi J, Han K, Seo J (2009) Synaptic removal of diacylglycerol by DGKζ and PSD-95 regulates dendritic spine maintenance. EMBO J 28(8):1170–1179
Chaouloff F, Hemar A, Manzoni OJ (2007) Acute stress facilitates hippocampal CA1 metabotropic glutamate receptor-dependent long-term depression. J Neurosci 27(27):7130–7135
Andreasen JT, Gynther M, Rygaard A, Bøgelund T, Nielsen SD, Clausen RP, Mogensen J, Pickering DS (2013) Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests. Neurosci Lett 546:6–10
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant Numbers 81873096, 81603227, 81503465, 81460645), Chanzhou Sci & Tech Program (2017333), Ningxia key research and development plan (2016KJHM46), Eastern United Western Science and Technology Cooperation Project (2017BY079).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Xiao, D., Liu, L., Li, Y. et al. Licorisoflavan A Exerts Antidepressant-Like Effect in Mice: Involvement of BDNF-TrkB Pathway and AMPA Receptors. Neurochem Res 44, 2044–2056 (2019). https://doi.org/10.1007/s11064-019-02840-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-019-02840-2